$2.98
-0.0009-0.03%
Last update: Nov 6, 1:03 PM
Galectin Therapeutics Inc
GALTNASDAQ
The average analyst price target for Galectin Therapeutics is $8.50, 184.8% above the current price. The one analyst covering it rates it Buy. Targets range from $6 to $11. The latest change came on Dec 17, 2025, when HC Wainwright & Co. raised its price target on Galectin Therapeutics from $6 to $11 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
